Fluorescein Sodium

  • # LGM Pharma is a Fluorescein Sodium CAS# 518-47-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Fluorescein Sodium
  • CAS #: 518-47-8
  • IUPAC: disodium;3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate
  • PubChem: 9885981
  • Formula: C20H10Na2O5
  • Synonyms: Uranine, Sodium fluorescein, Fluorescein sodium, Fluorescein disodium salt, NaFluo, NaFl, ACID YELLOW 73, MFCD00167039, Fluorescein, disodium salt, C.I. Acid yellow 73 (fluorescein sodium), DSSTox_CID_5328, DSSTox_RID_77750, Disodium 2-(3-oxo-6-oxidoxanthen-9-yl)benzoate, DSSTox_GSID_25328, CAS-518-47-8, fluorescein disodium, Fluor-I-strip A.T, SCHEMBL24115, Fluorescein sodium [BAN:JAN], CHEMBL1200433, DTXSID9025328, RGPLGPBQJOQFJS-UHFFFAOYSA-L, Tox21_111592, GT1410, GT3976, LS-169, Fluorescein, Disodium Salt (Uranine), AKOS016844149, Tox21_111592_1, NCGC00161643-05, C.I. 5350, ST24031638, Fluorescein sodium salt, 98% (C.I. 45350), disodium;3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate
  • SMILES: C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)[O-])OC5=C3C=CC(=C5)[O-].[Na+].[Na+]
  • InChl: InChI=1S/C20H12O5.2Na/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20;;/h1-10,21-22H;;/q;2*+1/p-2
  • Product Description:

    FLUORESCEIN, DISODIUM SALT is an orange-red to dark red powder. Water-soluble form of fluorescein. Odorless and almost tasteless. pH (5% solution) 7.8. May be sensitive to prolonged exposure to light and to heat. A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service